Data Supporting Use of Predictive Enrichment Markers for Lumos Pharma’s LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
Go back to Data Supporting Use of Predictive Enrichment Markers for Lumos Pharma’s LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society| (NASDAQ: LUMO) | Delayed: 2.76 -0.04 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.80 | 52 Week High | $ | |||
| Open | $2.71 | 52 Week Low | $ | |||
| Day High | $2.81 | P/E | N/A | |||
| Day Low | $2.71 | EPS | $ | |||
| Volume | 1,569 | |||||
